An Evaluation of FrancoForme


Stephanie A. Prince , MSc, PhD ; Marc Laflamme , PT ; Jennifer Harris , PT ; Heather E. Tulloch , PhD, CPsych ; Michele de Margerie , MD


Cardiovascular disease (CVD) is the leading cause of mortal globally. Telephone-delivered interventions targeting cardiovascular risk factors are gaining popularity. This study is an evaluation of FrancoForme, a cardiovascular risk factor reduction program for the primary and secondary prevention of CVD among French-speaking patients of Eastern Ontario.


This study reports on changes in cardiovascular risk factors weekly exercise levels, and psychosocial characteristics including anxiety, depression, and quality of life upon program completion (3 months) and at 1 year after the start of the program. Repeated-measures analysis of variance was used to compare changes in out-comes between primary prevention risk groups (low, moderate, and high risk for CVD) and the secondary prevention group (ie, cardiac rehabilitation) at baseline, 3 months and 12 months.


A total of 762 patients enrolled in FrancoForme between 2008 and 2015. At 3 months, all program completers (n = 507) experi-enced significant reductions for all cardiovascular risk factors except diastolic blood pressure. Minutes of self-reported exercise increased significantly by an average 90 minutes per week and all psychosocial variables improved. Significant group effects were observed across several risk factors. Among 12-month responders (n = 240), exercise, high-density lipoproteins, triglycerides, cholesterol, and all psychoso-cial variables were improved over baseline results.


FrancoForme is unique in targeting both the primary and secondary prevention of CVD and removes several of the barriers to participating in a conventional CVD prevention program for French-speaking patients. FrancoForme is successful, receiving high satisfac-tion rates and resulting in significant improvements in cardiovascular risk factors, exercise, anxiety, and depression, as well as quality of life.

Author Affiliations: Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ontario, Canada (Drs Prince, Tulloch, and Margerie, Ms Harris, and Mr Laflamme); and Faculty of Medicine, University of Ottawa, Ontario, Canada (Dr Tulloch).

All authors have read and approved the article.

The authors declare no conflicts of interest.

Correspondence : Stephanie A. Prince, MSc, PhD, Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada ( sprinceware@ottawaheart. ca ). DOI: 10.1097/HCR.0000000000000200